Healthcare technology company Hippocratic AI has announced the receipt of an investment from NVentures, the venture capital arm of NVIDIA, as part of an extended Series A funding round.
Alongside the contributions from 7Wire Ventures’ Leo Shapiro, and Greycroft, this investment adds an additional $17m to Hippocratic AI’s funding round.
The latest investment has further increased the total investment in Hippocratic AI to approximately $137m.
The initial phase of the Series A round was co-led by Premji Invest and General Catalyst, with SV Angel and Memorial Hermann Health System also participating.
Other existing investors in the initial Series A round included WellSpan Health, Andreessen Horowitz (a16z) Bio + Health, Cincinnati Children’s, and Universal Health Services, contributing a combined valuation of $500m.
Hippocratic AI’s partnership with NVIDIA will now focus on new technological developments.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataUsing NVIDIA NIM microservices, the company intends to enhance its existing production platform to deliver low-latency and improved long-context conversational capabilities.
This collaboration, which was unveiled at the NVIDIA GTC global artificial intelligence (AI) conference held this year, employs various techniques, such as speculative decoding, prefix caching, and prefill/decode disaggregation to facilitate real-time, long-context conversational AI.
In addition, Hippocratic AI is harnessing NVIDIA technologies to advance medical domain specialisation in Large Language Models (LLMs) through automated speech recognition technology, which is mainly fine-tuned for clinician-patient dialogue.
NVIDIA healthcare vice-president Kimberly Powell said: “Generative AI will expand the healthcare industry and its ability to serve the growing demands of patient care, and Hippocratic AI is putting the technology to work to increase access to healthcare.
“The company’s safety-focused approach uses advanced NVIDIA technologies to make personalised, real-time patient interactions more natural and capable, helping build trust among patients and clinicians alike.”
Hippocratic AI is working to create the first safety focused LLM for healthcare, with the aim to support a future where healthcare expertise is accessible to all, potentially revolutionising healthcare accessibility and outcomes globally.